Heelan, Bridget T <br/><br/>
Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome.  [electronic resource] 

 -  British journal of haematology  Sep 2002 
 - 1078-81 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2141.2002.03753.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD19--blood<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Autoimmune Diseases--drug therapy<br/>Child<br/>Combined Modality Therapy<br/>Humans<br/>Immunoglobulin G--blood<br/>Lymphoproliferative Disorders--drug therapy<br/>Male<br/>Mutation<br/>Platelet Count<br/>Proteins--genetics<br/>Rituximab<br/>TNF Receptor-Associated Factor 6<br/>Thrombocytopenia--drug therapy<br/>Vincristine--therapeutic use